博济医药(300404.SZ)：费米十三号减持0.30%公司股份 共计116.1万股

Core Viewpoint - 博济医药 has reported a significant share reduction by a major shareholder, which may impact the company's stock performance and investor sentiment [1] Shareholding Changes - The company received a notice from Fermi No. 13 regarding the reduction of shares, where Fermi No. 13 sold a total of 1.161 million shares between September 12, 2025, and October 17, 2025, representing 0.30% of the total share capital [1] - After this reduction, the controlling shareholder, Wang Tingchun, and his concerted action person, Zhao Lingli, along with Fermi No. 13, collectively hold 142 million shares, accounting for 36.88% of the total share capital [1] - The equity change triggered a 1% integer multiple threshold [1]